載入...
Factor XI(a) inhibitors for thrombosis: an updated patent review (2016-present)
INTRODUCTION: Anticoagulation without bleeding is an ideal goal in treating thrombosis, however, this goal has not been achieved. All current anticoagulants are associated with significant bleeding which limits their safe use. Genetic and pharmacological findings indicate that factor XIa is a key pl...
Na minha lista:
| 發表在: | Expert Opin Ther Pat |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515655/ https://ncbi.nlm.nih.gov/pubmed/31847619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13543776.2020.1705783 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|